Tolerability and pharmacokinetics of single ascending doses of AFN 1252 in healthy subjects

Trial Profile

Tolerability and pharmacokinetics of single ascending doses of AFN 1252 in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 02 May 2012

At a glance

  • Drugs Debio 1452 (Primary)
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Adverse reactions
  • Sponsors Affinium Pharmaceuticals
  • Most Recent Events

    • 02 May 2012 Status changed from recruiting to completed.
    • 07 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top